Paoletti M, Marcellusi A, Yang J, Mennini FS. Cost-effectiveness of IMI/CIL/REL for the treatment of carbapenem non-susceptible Gram-negative bacterial infections. Grhta [Internet]. 2023 Apr. 11 [cited 2024 Nov. 23];10(1):18-2. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/2488